Industry News
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Ajinomoto, XL-protein Forge Strategic Alliance
Ajinomoto will apply its Corynex expression system with XL-protein's PASylation technology to develop a series of therapeutic compounds12.18.18
-
Biosimilars | Breaking News | Drug Development | Industry News
Alvotech, Fuji Pharma Expand Biosimilars Alliance
Fuji invests $50 million in Alvotech, expands development and commercialization of biosimilars in Japan12.18.18
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Roquette & Thermo Fisher Enter Distribution Deal
For the Roquette portfolio of pharmaceutical ingredients in the United States and Canada12.18.18
-
Breaking News | Drug Development | Industry News
Selexis, Teneobio Enter Second Services Agreement
Will utilize Selexis’ SUREtechnology Platform to develop research cell banks for three additional preclinical candidates12.18.18
-
Breaking News | Drug Development | Industry News
Lilly Acquires Hydra Biosciences’ Pain Asset
Preclinical program of TRPA1 antagonists being studied for the potential treatment of chronic pain12.17.18
-
Breaking News | cGMP Manufacture | Drug Development | Industry News
Rentschler Biopharma Buys U.S. Mfg. Site from Shire
Will leverage the development and manufacturing site for CDMO services12.17.18
-
Bio News | Clinical Trials | Industry News | R&D
Neurotrope Announces Publication of Phase 2 Alzheimer's Study
The multidose, exploratory trial was to evaluate Bryostatin-1 as a treatment of cognitive deficits in moderate to severe Alzheimer's disease12.17.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Proteostasis & Genentech Sign Licensing Deal
For rights to potential therapeutic small molecule modulators of an undisclosed target within the proteostasis network12.17.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News | Laboratory Testing | R&D
Alkermes, Biogen Submit NDA to FDA
For diroximel fumarate (BIIB098), a novel oral fumarate in development for the treatment of relapsing forms of multiple sclerosis12.17.18
-
Breaking News | Drug Development | Industry News
Astellas Pharma Acquires Potenza Therapeutics
Successful collaboration results in three INDs with the potential to treat various cancers12.17.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
KIO, Pfizer Enter Research Collaboration
To develop RIG-I agonist immunotherapies for the treatment of cancer12.17.18
-
Bio News | Collaborations & Alliances | Drug Development | Industry News | R&D
Orchard & SIRION Enter License Agreement
SIRION to provide Orchard with a license to its proprietary lentiviral transduction enhancer LentiBOOST™12.14.18
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
CTI BioPharma Corp. Restructures
Workforce reductions have been implemented that impact approximately 50 percent of the company's employees12.14.18
-
Bio News | Drug Development | Facilities | Industry News | Promotions & Moves | R&D
HemaCare Moves Into New HQ
Company has officially moved its global headquarters to Northridge, California, in a 40,000 sq. ft. building in the heart of the San Fernando ValleyVideos
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Q BioMed, SRI Enter ASD Collaboration
To provide formulation development, preclinical development, and early clinical manufacturing of QBM-001 for non-verbal or minimally verbal autistic children12.13.18
-
Bio News | Industry News | Promotions & Moves
Rentschler Biopharma Appoints Innovation SVP
Dr. Jesús Zurdo will provide scientific leadership for development and manufacturing services from cell-line development through to final product manufacturing12.13.18
-
Bio News | Collaborations & Alliances | Industry News
AMAG Acquires Perosphere
AMAG will acquire global rights to Perosphere's ciraparantag, a next generation anticoagulant reversal agent12.13.18
-
Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
WuXi Biologics Advances Cell Culture Productivity
WuXiUP technology enables 1,000L disposable bioreactors to achieve comparable productivity as traditional 10,000-20,000L stainless bioreactors12.12.18
-
Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
Novo Nordisk Purchases Berkeley Lights Beacon Platform
Aims to reduce the extensive resources typically required to generate a cell line for commercial production12.12.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing | R&D
AC Immune & Lilly Partner for Alzheimer's
The license and collaboration agreement is to research and develop tau aggregation inhibitor small molecules for the potential treatment of AD12.12.18
